Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $117B |
| FY2017, ended Dec 31, 2017 | $93.3B |
| FY2018, ended Dec 31, 2018 | $49.9B |
| FY2019, ended Dec 31, 2019 | $55.7B |
| FY2020, ended Dec 31, 2020 | $30.4B |
| FY2021, ended Dec 31, 2021 | $42.0B |
| FY2022, ended Dec 31, 2022 | $75.9B |
| FY2023, ended Dec 31, 2023 | $74.3B |
| FY2024, ended Dec 31, 2024 | $53.7B |
| FY2025, ended Dec 31, 2025 | $57.4B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $71.9B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $27.8B |
| FY2017, ended Dec 31, 2017 | $30.4B |
| FY2018, ended Dec 31, 2018 | $32.8B |
| FY2019, ended Dec 31, 2019 | $32.9B |
| FY2020, ended Dec 31, 2020 | $23.6B |
| FY2021, ended Dec 31, 2021 | $22.9B |
| FY2022, ended Dec 31, 2022 | $28.1B |
| FY2023, ended Dec 31, 2023 | $33.1B |
| FY2024, ended Dec 31, 2024 | $36.3B |
| FY2025, ended Dec 31, 2025 | $35.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $36.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$1.69B | $4.21B |
| FY2017, ended Dec 31, 2017 | −$1.50B | $3.56B |
| FY2018, ended Dec 31, 2018 | $2.14B | $3.55B |
| FY2019, ended Dec 31, 2019 | −$10.1B | $3.71B |
| FY2020, ended Dec 31, 2020 | −$10.5B | $1.83B |
| FY2021, ended Dec 31, 2021 | $1.88B | $3.51B |
| FY2022, ended Dec 31, 2022 | $3.44B | $2.10B |
| FY2023, ended Dec 31, 2023 | $4.20B | $4.70B |
| FY2024, ended Dec 31, 2024 | $4.46B | $4.67B |
| FY2025, ended Dec 31, 2025 | $3.37B | $4.79B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.10B | $4.56B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.93B |
| FY2017, ended Dec 31, 2017 | $1.80B |
| FY2018, ended Dec 31, 2018 | $1.43B |
| FY2019, ended Dec 31, 2019 | $1.14B |
| FY2020, ended Dec 31, 2020 | $844M |
| FY2021, ended Dec 31, 2021 | $1.76B |
| FY2022, ended Dec 31, 2022 | $1.66B |
| FY2023, ended Dec 31, 2023 | $2.90B |
| FY2024, ended Dec 31, 2024 | $3.54B |
| FY2025, ended Dec 31, 2025 | $3.04B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.62B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $19.6B |
| FY2017, ended Dec 31, 2017 | $14.9B |
| FY2018, ended Dec 31, 2018 | $14.6B |
| FY2019, ended Dec 31, 2019 | $14.8B |
| FY2020, ended Dec 31, 2020 | $16.0B |
| FY2021, ended Dec 31, 2021 | $13.3B |
| FY2022, ended Dec 31, 2022 | $10.6B |
| FY2023, ended Dec 31, 2023 | $10.8B |
| FY2024, ended Dec 31, 2024 | $11.0B |
| FY2025, ended Dec 31, 2025 | $9.74B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $11.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 6.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.39B |
| FY2017, ended Dec 31, 2017 | 1.38B |
| FY2018, ended Dec 31, 2018 | 1.38B |
| FY2019, ended Dec 31, 2019 | 1.38B |
| FY2020, ended Dec 31, 2020 | 1.39B |
| FY2021, ended Dec 31, 2021 | 1.40B |
| FY2022, ended Dec 31, 2022 | 1.42B |
| FY2023, ended Dec 31, 2023 | 1.43B |
| FY2024, ended Dec 31, 2024 | 1.40B |
| FY2025, ended Dec 31, 2025 | 1.50B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 1.48B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees | Used in acquisitions |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $267M | — |
| FY2017, ended Dec 31, 2017 | $343M | — |
| FY2018, ended Dec 31, 2018 | $345M | — |
| FY2019, ended Dec 31, 2019 | $405M | — |
| FY2020, ended Dec 31, 2020 | $397M | — |
| FY2021, ended Dec 31, 2021 | $324M | — |
| FY2022, ended Dec 31, 2022 | $313M | — |
| FY2023, ended Dec 31, 2023 | $293M | $1.25B |
| FY2024, ended Dec 31, 2024 | $316M | — |
| FY2025, ended Dec 31, 2025 | $332M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $326M | — |
Valuation
At current price- Market Cap
- $79.8B
- P/E
- 25.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.2×
- Price / Book
- 3.1×
- EV / EBITDA
- 12.2×
Growth
Trailing 12 months- Revenue (TTM)
- $36.9B
- Revenue Growth YoY
- 4.7%
- Revenue CAGR 3Y
- 8.3%
- Revenue CAGR 5Y
- 8.6%
- EPS Growth YoY
- −19.8%
- Net Income Growth YoY
- −15.0%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 8.4%
- FCF Margin
- 12.4%
- Return on Equity
- 12.0%
Earnings
Trailing 12 months- Net Income
- $3.10B
- EPS (diluted)
- $2.06
- EBITDA
- $7.27B
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $2.62B
- Total Debt
- $11.1B
- Net Debt
- $8.53B
- Total Assets
- $56.2B
- Total Liabilities
- $29.0B
- Shareholders' Equity
- $26.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $6.36B
- Capital Expenditure
- $1.80B
- Free Cash Flow
- $4.56B
Dividends and risk
Last 12 months- Dividend Yield
- 2.2%
- Dividend / Share
- $1.17
- Beta (5Y)
- 0.83
Every ratio is calculated from the company’s reported figures.